What is MapLight Therapeutics, Inc. 's earnings yield?

MapLight Therapeutics, Inc. (MPLT) reported earnings yield of -23.1% in Q1 2026.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

MapLight Therapeutics, Inc. MPLT Earnings yield

Earnings yield at other companies

Bristol-Myers SquibbBMY

5.9%+1.6pp

Johnson & JohnsonJNJ

3.6%-1.9pp

Neurocrine BiosciencesNBIX

5.1%+2.3pp

Acadia PharmaceuticalsACAD

9.9%+1.6pp

AbbVieABBV

0.9%-0.2pp

MeiraGTx Holdings plcMGTX

-25.5%—

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B—

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Calculated from MapLight Therapeutics, Inc. ’s reported figures.

net income/market cap=-23.1%

Based on trailing twelve months.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's earnings yield?: MapLight Therapeutics, Inc. (MPLT) reported earnings yield of -23.1% in Q1 2026.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.